Shahid Iqbal
Research Subjects
Shahid Iqbal has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Peng Wu
Life Quality Engineering Interest Group, School of Chemical and Environmental Engineering, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, Jiangsu 215123, China
5 shared publications Rizwan Ahmed Bhutto
5 shared publicationsXiao Dong Chen
5 shared publicationsHaozhi Chen
4 shared publicationsRonggang Pan
4 shared publications- Xiao Dong Chen
Life Quality Engineering Interest Group, School of Chemical and Environmental Engineering, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, China
4 shared publications
Latest Publications
- Open Access
- 22 July 2026
- Published by University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca in Notulae Botanicae Horti Agrobotanici Cluj-Napoca
- Vol. 54  (3)
Adaptation of Exotic Buckwheat Germplasm to an Arid Low-Altitude Subtropical Environment: Phenology and Yield under Two Sowing Windows
Introducing orphan crops into current farming systems can enhance nutritional security. Buckwheat is a crop that can help agricultural sustainability by growing in multiple environments, using minimal inputs, providing balanced nutrients and addressing malnutrition. Since buckwheat is a short-duration crop that produces grains having a balanced nutritional profile, it can be adjusted in existing cropping systems. As buckwheat has traditionally been cultivated in hilly regions, its introduction into the low-altitude plains requires evaluation of germplasm adaptability. One hundred and forty-eight exotic genotypes were screened for adaptability under two sowing dates using randomized complete block design under split-plot arrangements in Multan, Pakistan. Data regarding yield and yield related traits were recorded. Significant differences were found among 93 germinated genotypes out of total sown 148 genotypes of Buckwheat regarding yield and yield related traits. The flowering initiation period ranged from 23 to 34 days, number of cymes per plant were found between 1 to 7. The adapted genotypes produced the highest number of seeds per cyme, with a maximum of four seeds per cyme, Genotypes matured between 68 to 87 days, biomass per plant values ranged between 7 to 16 g and genotype Silverhull-24 produced more weighted seeds (1000 seed weight 34 g). Among the tested diversity, only two genotypes Silverhull-24 (origin uncertain) and Japanese B+0 IR-13 (from Japan) were found adaptable. This restricted adaptability may be due to the predominance of buckwheat germplasm originating from high-altitude temperate regions, whereas the experimental site in Multan represents a low-altitude tropical environment. The adaptation of only two genotypes indicates the need for wider germplasm evaluation and breeding initiatives to develop buckwheat types suited to plain agro-ecologies.
- 22 July 2026
- Published by University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca in Notulae Botanicae Horti Agrobotanici Cluj-Napoca
- Vol. 54  (3)
Open AccessAdaptation of Exotic Buckwheat Germplasm to an Arid Low-Altitude Subtropical Environment: Phenology and Yield under Two Sowing Windows
Introducing orphan crops into current farming systems can enhance nutritional security. Buckwheat is a crop that can help agricultural sustainability by growing in multiple environments, using minimal inputs, providing balanced nutrients and addressing malnutrition. Since buckwheat is a short-duration crop that produces grains having a balanced nutritional profile, it can be adjusted in existing cropping systems. As buckwheat has traditionally been cultivated in hilly regions, its introduction into the low-altitude plains requires evaluation of germplasm adaptability. One hundred and forty-eight exotic genotypes were screened for adaptability under two sowing dates using randomized complete block design under split-plot arrangements in Multan, Pakistan. Data regarding yield and yield related traits were recorded. Significant differences were found among 93 germinated genotypes out of total sown 148 genotypes of Buckwheat regarding yield and yield related traits. The flowering initiation period ranged from 23 to 34 days, number of cymes per plant were found between 1 to 7. The adapted genotypes produced the highest number of seeds per cyme, with a maximum of four seeds per cyme, Genotypes matured between 68 to 87 days, biomass per plant values ranged between 7 to 16 g and genotype Silverhull-24 produced more weighted seeds (1000 seed weight 34 g). Among the tested diversity, only two genotypes Silverhull-24 (origin uncertain) and Japanese B+0 IR-13 (from Japan) were found adaptable. This restricted adaptability may be due to the predominance of buckwheat germplasm originating from high-altitude temperate regions, whereas the experimental site in Multan represents a low-altitude tropical environment. The adaptation of only two genotypes indicates the need for wider germplasm evaluation and breeding initiatives to develop buckwheat types suited to plain agro-ecologies.
- 1 February 2025
- Published by Springer Nature
- p. 131-196
Designing Smart and Sustainable Edible Packaging Materials from Biopolymers, Proteins, and Polysaccharides
- 1 February 2025
- Published by Springer Nature
- p. 131-196
Designing Smart and Sustainable Edible Packaging Materials from Biopolymers, Proteins, and Polysaccharides
- 30 October 2024
- Published by Elsevier in Food Hydrocolloids
- Vol. 160
Alteration in rheological and digestive properties of O/W emulsions using controlled aggregation of konjac glucomannan and xanthan gum in aqueous phases
- 30 October 2024
- Published by Elsevier in Food Hydrocolloids
- Vol. 160
Alteration in rheological and digestive properties of O/W emulsions using controlled aggregation of konjac glucomannan and xanthan gum in aqueous phases
- 12 June 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 273  (Pt 1) , 132964
Enhancing rheology and reducing lipid digestion of oil-in-water emulsions using controlled aggregation and heteroaggregation of soybean protein isolate-peach gum microspheres
- 12 June 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 273  (Pt 1) , 132964
Enhancing rheology and reducing lipid digestion of oil-in-water emulsions using controlled aggregation and heteroaggregation of soybean protein isolate-peach gum microspheres
- 28 March 2024
- Published by Elsevier in Journal of Food Engineering
- Vol. 375
Impact of chitosan/metal oxide-based blends on the rheology, stability, and microstructures of oil-in-water emulsions
- 28 March 2024
- Published by Elsevier in Journal of Food Engineering
- Vol. 375
Impact of chitosan/metal oxide-based blends on the rheology, stability, and microstructures of oil-in-water emulsions
- 19 December 2023
- Published by Elsevier in Food Hydrocolloids
- Vol. 150
Polyelectrolyte nanocomplex from sodium caseinate and chitosan as potential vehicles for oil encapsulation by flash nanoprecipitation
- 19 December 2023
- Published by Elsevier in Food Hydrocolloids
- Vol. 150
Polyelectrolyte nanocomplex from sodium caseinate and chitosan as potential vehicles for oil encapsulation by flash nanoprecipitation
- Open Access
- 21 June 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16  (7) , 909
Investigation of Novel Benzoxazole-Oxadiazole Derivatives as Effective Anti-Alzheimer’s Agents: In Vitro and In Silico Approaches
Alzheimer’s disease (AD) is a progressive neurological illness that is distinguished clinically by cognitive and memory decline and adversely affects the people of old age. The treatments for this disease gained much attention and have prompted increased interest among researchers in this field. As a springboard to explore new anti-Alzheimer’s chemical prototypes, the present study was carried out for the synthesis of benzoxazole-oxadiazole analogues as effective Alzheimer’s inhibitors. In this research work, we have focused our efforts to synthesize a series of benzoxazole-oxadiazole (1–19) and evaluating their anti-Alzheimer properties. In addition, the precise structures of synthesized derivatives were confirmed with the help of various spectroscopic techniques including 1H-NMR, 13C-NMR and HREI-MS. To find the anti-Alzheimer potentials of the synthesized compounds (1–19), in vitro acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), inhibitory activities were performed using Donepezil as the reference standard. From structure-activity (SAR) analysis, it was confirmed that any variation found in inhibitory activities of both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes were due to different substitution patterns of substituent(s) at the variable position of both acetophenone aryl and oxadiazole aryl rings. The results of the anti-Alzheimer assay were very encouraging and showed moderate to good inhibitory potentials with IC50 values ranging from 5.80 ± 2.18 to 40.80 ± 5.90 µM (against AChE) and 7.20 ± 2.30 to 42.60 ± 6.10 µM (against BuChE) as compared to standard Donepezil drug (IC50 = 33.65 ± 3.50 µM (for AChE) and 35.80 ± 4.60 µM (for BuChE), respectively. Specifically, analogues 2, 15 and 16 were identified to be significantly active, even found to be more potent than standard inhibitors with IC50 values of 6.40 ± 1.10, 5.80 ± 2.18 and 6.90 ± 1.20 (against AChE) and 7.50 ± 1.20, 7.20 ± 2.30 and 7.60 ± 2.10 (against BuChE). The results obtained were compared to standard drugs. These findings reveal that benzoxazole-oxadiazole analogues act as AChE and BuChE inhibitors to develop novel therapeutics for treating Alzheimer’s disease and can act as lead molecules in drug discovery as potential anti-Alzheimer agents.
- 21 June 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16  (7) , 909
Open AccessInvestigation of Novel Benzoxazole-Oxadiazole Derivatives as Effective Anti-Alzheimer’s Agents: In Vitro and In Silico Approaches
Alzheimer’s disease (AD) is a progressive neurological illness that is distinguished clinically by cognitive and memory decline and adversely affects the people of old age. The treatments for this disease gained much attention and have prompted increased interest among researchers in this field. As a springboard to explore new anti-Alzheimer’s chemical prototypes, the present study was carried out for the synthesis of benzoxazole-oxadiazole analogues as effective Alzheimer’s inhibitors. In this research work, we have focused our efforts to synthesize a series of benzoxazole-oxadiazole (1–19) and evaluating their anti-Alzheimer properties. In addition, the precise structures of synthesized derivatives were confirmed with the help of various spectroscopic techniques including 1H-NMR, 13C-NMR and HREI-MS. To find the anti-Alzheimer potentials of the synthesized compounds (1–19), in vitro acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), inhibitory activities were performed using Donepezil as the reference standard. From structure-activity (SAR) analysis, it was confirmed that any variation found in inhibitory activities of both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes were due to different substitution patterns of substituent(s) at the variable position of both acetophenone aryl and oxadiazole aryl rings. The results of the anti-Alzheimer assay were very encouraging and showed moderate to good inhibitory potentials with IC50 values ranging from 5.80 ± 2.18 to 40.80 ± 5.90 µM (against AChE) and 7.20 ± 2.30 to 42.60 ± 6.10 µM (against BuChE) as compared to standard Donepezil drug (IC50 = 33.65 ± 3.50 µM (for AChE) and 35.80 ± 4.60 µM (for BuChE), respectively. Specifically, analogues 2, 15 and 16 were identified to be significantly active, even found to be more potent than standard inhibitors with IC50 values of 6.40 ± 1.10, 5.80 ± 2.18 and 6.90 ± 1.20 (against AChE) and 7.50 ± 1.20, 7.20 ± 2.30 and 7.60 ± 2.10 (against BuChE). The results obtained were compared to standard drugs. These findings reveal that benzoxazole-oxadiazole analogues act as AChE and BuChE inhibitors to develop novel therapeutics for treating Alzheimer’s disease and can act as lead molecules in drug discovery as potential anti-Alzheimer agents.